Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Cheng, Wan Li ^a   Tsai, Ming Ming ^a,b   Tsai, Chung Ying ^a   Huang, Ya Hui ^c   Chen, Cheng Yi ^a   Chi, Hsiang Cheng ^a   Tseng, Yi Hsin ^a   Chao, Im Wai ^a   Lin, Wei Chi ^a   Wu, Sheng Ming ^a   Liang, Ying ^a   Liao, Chia Jung ^a   Lin, Yang Hsiang ^a   Chung, I Hsiao ^a   Chen, Wei Jan ^c   Lin, Paul Y ^c   Wang, Chia Siu ^c   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOYLGLUTATHIONE LYASE; SHORT HAIRPIN RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH WALL; SURVIVAL TIME; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; PROGNOSIS; STOMACH; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84859065860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034352     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Department of Health, Taiwan (Department of Health, Taiwan. Cause of death statistics. 2010 [assessed April 7th 2010].
3. Wang CS, Hsieh CC, Chao TC, Jan YY, Jeng LB, et al. (2002) Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J 25: 216-227.
4. Steeg PS, (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55-63.
5. Mao XY, Wang XG, Lv XJ, Xu L, Han CB, (2007) COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray. World J Gastroenterol 13: 3466-3471.
6. Yao JC, Wang L, Wei D, Gong W, Hassan M, et al. (2004) Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10: 4109-4117.
7. Konno H, Ohta M, Baba M, Suzuki S, Nakamura S, (2003) The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Sci 94: 735-740.
8. Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y, et al. (2011) Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol 22: 2267-2276.
9. Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, et al. (2009) Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 5: e1000676.
10. Thornalley PJ, (1995) Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor. Crit Rev Oncol Hematol 20: 99-128.
11. Ranganathan S, Ciaccio PJ, Walsh ES, Tew KD, (1999) Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene 240: 149-155.
12. Thornalley PJ, (2008) Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabol Drug Interact 23: 125-150.
13. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, et al. (2005) Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 4: 1686-1696.
14. Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, et al. (2009) CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 9: 115.
15. Romanuik TL, Ueda T, Le N, Haile S, Yong TM, et al. (2009) Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol 175: 2264-2276.
16. Bair WB 3rd, Cabello CM, Uchida K, Bause AS, Wondrak GT, (2010) GLO1 overexpression in human malignant melanoma. Melanoma Res 20: 85-96.
17. Thornalley PJ, Rabbani N, (2011) Glyoxalase in tumourigenesis and multidrug resistance. Semin Cell Dev Biol 22: 318-325.
18. Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S, (2004) Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Br J Cancer 91: 1924-1930.
19. Japanese Gastric Cancer A, (1998) Japanese Classification of Gastric Carcinoma- 2nd English Edition. Gastric Cancer 1: 10-24.
20. Greene FL, Page DL, Fleming ID, (2002) AJCC Cancer Staging Manual.6th ed New York Springer-Verlag pp. 99-106.
21. Huang YH, Lee CY, Tai PJ, Yen CC, Liao CY, et al. (2006) Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones. Endocrinology 147: 2481-2489.
22. Wu CC, Chien KY, Tsang NM, Chang KP, Hao SP, et al. (2005) Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5: 3173-3182.
23. Hsu SM, Raine L, Fanger H, (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75: 816-821.
24. Hsu SM, Raine L, Fanger H, (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580.
25. Goulding H, Pinder S, Cannon P, Pearson D, Nicholson R, et al. (1995) A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 26: 291-294.
26. Lin KH, Wang WJ, Wu YH, Cheng SY, (2002) Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor. Endocrinology 143: 467-475.
27. Tsai MS, Hwang SM, Chen KD, Lee YS, Hsu LW, et al. (2007) Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25: 2511-2523.
28. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A, (2005) A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 158: 20-29.
29. Tsujimoto H, Ono S, Ichikura T, Matsumoto Y, Yamamoto J, et al. (2011) Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes? Gastric Cancer 13: 212-221.
30. Ceradini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, et al. (2008) Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 283: 10930-10938.
31. Sodhi A, Montaner S, Gutkind JS, (2004) Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5: 998-1012.
32. Westermarck J, Kahari VM, (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792.
33. Liu XE, Sun XD, Wu JM, (2004) Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol 10: 352-355.
34. Thornalley PJ, Edwards LG, Kang Y, Wyatt C, Davies N, et al. (1996) Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. Biochem Pharmacol 51: 1365-1372.
35. Kavarana MJ, Kovaleva EG, Creighton DJ, Wollman MB, Eiseman JL, (1999) Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum. J Med Chem 42: 221-228.
36. Sakamoto H, Mashima T, Kizaki A, Dan S, Hashimoto Y, et al. (2000) Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95: 3214-3218.
37. Dang CV, Semenza GL, (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68-72.
38. Bedogni B, Powell MB, (2009) Hypoxia, melanocytes and melanoma- survival and tumor development in the permissive microenvironment of the skin. Pigment Cell Melanoma Res 22: 166-174.
39. Rohwer N, Lobitz S, Daskalow K, Jons T, Vieth M, et al. (2009) HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer 100: 772-781.
40. Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM, (2005) Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 41: 2792-2805.
41. Rohwer N, Dame C, Haugstetter A, Wiedenmann B, Detjen K, et al. (2010) Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB. PLoS One 5: e12038.
42. Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, et al. (2007) Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 7: 155-167.
43. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, et al. (2008) Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 123: 1787-1796.